Clinical Trial Update: Comparison of Dendritic Cells Versus Montanide as Adjuvants in a Melanoma Vaccine [Phase 1]

View source ↗

Summary

Phase 1 trial comparing dendritic cells versus Montanide as adjuvants in a melanoma vaccine; study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic cells
• Montanide ISA adjuvant (Montanide ISA)

Snippet

Sponsor: Dr. Nina Bhardwaj | Conditions: Melanoma | Phase 1 | Status: COMPLETED